SCHEMBL7975137

SCHEMBL7975137

Cc1ccc(Cn2cnc3nc(CCN)nc(O)c32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
CYP11B1 P15538 2/20 0.42
CYP11B2 P19099 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 1/20 0.42
CYP1A2 P05177 2/20 0.37
CYP2A6 P11509 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
BACE1 P56817 1/20 0.34
MET P08581 2/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HPGD P15428 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NR3C1 P04150 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989377 0.90 LMNA (0.44) LMNACYP11B1CYP11B2SMN1; SMN2HTT
SCHEMBL7974304 0.88 MET (0.44) CYP11B1CYP11B2SMN1; SMN2HTTTAAR1
SCHEMBL7985637 0.88 SMN1; SMN2 (0.43) CYP11B1CYP11B2SMN1; SMN2HPGDKMT2A
SCHEMBL7985639 0.87 ABCC8 (0.44) CYP11B1CYP11B2METHPGD
Hydrochloric Acid SCHEMBL7987616 0.86 SMN1; SMN2 (0.42) CYP11B1CYP11B2SMN1; SMN2HPGDKMT2A
SCHEMBL7992186 0.86 CYP11B1 (0.47) LMNACYP11B1CYP11B2SMN1; SMN2HTT
SCHEMBL7987434 0.86 CYP11B1 (0.42) LMNACYP11B1CYP11B2SMN1; SMN2HTT
SCHEMBL7988035 0.83 SMN1; SMN2 (0.39) LMNACYP11B1CYP11B2SMN1; SMN2HTT
Hydrochloric Acid SCHEMBL7988141 0.82 SMN1; SMN2 (0.39) LMNACYP11B1CYP11B2SMN1; SMN2HTT
SCHEMBL7988674 0.81 SMN1; SMN2 (0.43) CYP11B1CYP11B2SMN1; SMN2HTTTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed